Retrospective Multinational Chart Review Studies of Adverse and Serious Adverse Events in Europe: Opportunities and Challenges

被引：0
|
作者：
Payne, Krista A. [1 ,2 ]
Stein, Dara [1 ,2 ]
De Cock, Erwin [1 ,2 ]
机构：
[1] United BioSource Corp, Peri Approval Serv, Dorval, PQ, Canada
[2] United BioSource Corp, Post Approval Serv, Dorval, PQ, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
128
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [41] Nature, Occurrence and Consequences of Medication-Related Adverse Events During HospitalizationA Retrospective Chart Review in the Netherlands
    Lilian H.F. Hoonhout
    Martine C. de Bruijne
    Cordula Wagner
    Henk Asscheman
    Gerrit van der Wal
    Maurits W. van Tulder
    Drug Safety, 2010, 33 : 853 - 864
  • [42] Time Course Profile of Adverse Events of Interest and Serious Adverse Events With Darolutamide in the ARAMIS Trial
    Grabbert, Markus
    Gratzke, Christian
    Fizazi, Karim
    Shore, Neal
    Smith, Matthew
    Feyerabend, Susan
    Carles, Joan
    Lebret, Thierry
    Vjaters, Egils
    Werbrouck, Patrick
    Miskic, Marina
    Schmall, Anja
    Le Berre, Marie Aude
    Borghesi, Gustavo
    Verholen, Frank
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 105 - 105
  • [43] SURVEILLANCE OF ADVERSE EVENTS AND SERIOUS ADVERSE EVENTS DURING VACCINE TRIAL: EXPERIENCE OF CVD MALI
    Doumbia, Moussa
    Haidara, Fadima Cheick
    Diallo, Fatoumata
    Coulibaly, Flanon
    Coulibaly, Adama
    Tapia, Milagritos D.
    Sow, Samba O.
    Kotloff, Karen
    Levine, Myron M.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 362 - 362
  • [44] Time Course Profile of Adverse Events of Interest and Serious Adverse Events With Darolutamide in the ARAMIS Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 13 - 14
  • [45] Time course profile of adverse events of interest and serious adverse events with darolutamide in the ARAMIS trial
    Gratzke, C. J.
    Fizazi, K.
    Shore, N. D.
    Smith, M. R.
    Feyerabend, S.
    Grabbert, M.
    Carles, J.
    Lebret, T.
    Vjaters, E.
    Werbrouck, P.
    Miskic, M.
    Ortiz, J.
    Schmall, A.
    Le Berre, M. A.
    Verholen, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S664 - S664
  • [46] Serious adverse events in the transition period of the newborn
    Mena N, Patricia
    Novoa P, Jose Manuel
    Cortes C, Juan Pablo
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2013, 84 (02): : 177 - 181
  • [47] Human albumin: serious adverse events rare
    Reactions Weekly, 2003, 980 (1) : 4 - 4
  • [48] Isotretinoin (Accutane) and serious psychiatric adverse events
    O'Connell, KA
    Wilkin, JK
    Pitts, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (02) : 306 - 308
  • [49] No association of HPV vaccination with serious adverse events
    Caskey, Rachel
    JOURNAL OF PEDIATRICS, 2014, 164 (05): : 1240 - 1240
  • [50] Serious adverse events and the Modafinil Augmentation Study
    Block, J
    CNS SPECTRUMS, 2006, 11 (05) : 340 - 340
12345